Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Precise™ MRD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Myriad Genetics
Type:
Laboratory Developed Test
Related tests:
‹
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ Tumor Molecular Profile Test
Prolaris®
myPath Melanoma
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ Tumor Molecular Profile Test
Prolaris®
myPath Melanoma
›
Details
Evidence
News
Monitoring test based on whole genome sequencing to deeply interrogate tumor and detect recurrence earlier and help guide treatment decisions.
Method:
Whole genome sequencing
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login